Diabetes News and Research

Latest Diabetes News and Research

Concordia Healthcare reports record revenues of 147% in third quarter 2014

Concordia Healthcare Corp. ("Concordia" or the "Company"), a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced its financial and operational results for the three and nine months ended September 30, 2014.

14 Nov 2014

AADE offers self-care tips for people with diabetes

From Thanksgiving through New Year's Day, the holidays can be fun and heartwarming. They can also be exhausting and stressful.

14 Nov 2014

Eye screenings of underserved populations reveal one in five has early stage diabetic retinopathy

Eye screenings of people with diabetes in underserved communities revealed that one in five had early stage diabetic retinopathy, according to a new study by a research consortium including investigators at the University of Alabama at Birmingham.

13 Nov 2014

Scientists receive NARSAD Distinguished Investigator Grants for mental health research

The Brain & Behavior Research Foundation today announced the award of NARSAD Distinguished Investigator Grants valued at $1.5 million to 15 scientists, who are full professors or the equivalent, conducting innovative projects in diverse areas of neurobiological and behavioral research.

13 Nov 2014

Metabolic syndrome screening in bipolar disorder warranted

The frequency of the metabolic syndrome in patients with bipolar disorder warrants systematic screening, say researchers, particularly among men, older patients and those receiving atypical antipsychotic treatment.

12 Nov 2014

Study: Fast-food outlets in inner city neighborhoods linked to risk of diabetes, obesity

How close you are to fast-food outlets may be linked to your risk of Type-2 diabetes and obesity a new study led by the University of Leicester has discovered.

12 Nov 2014

Studies evaluate traditional management of heart attack patients after discharge from hospital

Beta-blockers have been a cornerstone in the treatment of heart attack survivors for more than a quarter of a century. However, many of the data predate contemporary medical therapy such as reperfusion, statins, and antiplatelet agents, and recent data have called the role of beta-blockers into question.

12 Nov 2014

Study examines overall survival of patients with chronic HCV infection, cirrhosis

Patients with chronic hepatitis C virus infection and advanced fibrosis or cirrhosis who attained sustained virological response (SVR) had survival comparable with that of the general population, whereas patients who did not attain SVR had reduced survival, according to a study in the November 12 issue of JAMA.

12 Nov 2014

Successful treatments help HIV-infected persons achieve similar longevity as those without HIV

New research from the Johns Hopkins Bloomberg School of Public Health suggests that HIV-infected adults are at a higher risk for developing heart attacks, kidney failure and cancer. But, contrary to what many had believed, the researchers say these illnesses are occurring at similar ages as adults who are not infected with HIV.

11 Nov 2014

Five simple steps to reduce type-2 diabetes

There are 29 million U.S. adults diagnosed with diabetes and an additional 1 in 3 diagnosed as pre-diabetic. Diabetes is a serious disease which can result in serious health complications including nerve damage, vision loss, heart disease, and kidney failure, to name a few.

11 Nov 2014

Stockholm researchers discover new mechanism that stimulates glucose uptake in brown fat

Research findings that can likely be used to develop a new type of medicine for type 2 diabetes are published today in the Journal of Cell Biology. Researchers at Stockholm University have discovered a new mechanism that stimulates glucose uptake in brown fat - a tissue whose primary function is to generate heat by burning fat and sugar.

11 Nov 2014

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with uncontrolled moderate-to-severe asthma. Dupilumab is an investigational therapy blocking IL-4 and IL-13, two cytokines required for the Th2 immune response.

11 Nov 2014

Study points to major role of obesity in triggering, prolonging autoimmune diseases

Autoimmune diseases like Crohn's Disease and multiple sclerosis, in which the immune system attacks its own body rather than predatory invaders, affect 5-20% of the global community. A study published recently in Autoimmunity Reviews by Prof. Yehuda Shoenfeld, the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases at Tel Aviv University's Sackler Faculty of Medicine and Head of Zabludowicz Center for Autoimmune Diseases at Chaim Sheba Medical Center, Tel Hashomer, points to the major role obesity plays in triggering and prolonging these autoimmune diseases.

11 Nov 2014

New model explains how immune cells recognize, destroy bacteria

The innate immune system serves as the body's specialized armed forces division, comprised of a host of defense mechanisms used to battle bacterial infections. Among the system's warriors are white blood cells including the specialized macrophages, which maintain constant surveillance for foreign intruders or pathogens, functioning as the body's first line of defense, poised to attack at barrier sites including the skin, lungs and intestines.

11 Nov 2014

Surgical treatment of obesity, diabetes as safe as other commonly performed surgical procedures

Laparoscopic gastric bypass surgery in patients with type 2 diabetes, once considered a high-risk procedure, carries a complication and mortality rate comparable to some of the safest and most commonly performed surgeries in America, including gallbladder surgery, appendectomy, and total knee replacement, according to new research from the Cleveland Clinic Bariatric and Metabolic Institute.

7 Nov 2014

Regenerative medicine may offer new standard of advanced treatment for foot and leg ulcers

These are exciting times for regenerative medicine. Unlike conventional medicines, the regenerative approach can potentially work to restore the lost functionality of tissues or organs—the major reason for intensive focus on research and development in the field.

7 Nov 2014

Health benefits of modified formulation of curcumin supplements

The health benefits of over-the-counter curcumin supplements might not get past your gut, but new research shows that a modified formulation of the spice releases its anti-inflammatory goodness throughout the body.

7 Nov 2014

Zinc supplements more beneficial for some people with diabetes

Researchers at the Johns Hopkins University School of Medicine and elsewhere have found that genetic differences may account for why zinc supplements are more beneficial to some people than to others for the prevention and control of diabetes. The results of their pilot study of a population of Old Order Amish is believed to be the first to point out the relevance of small genetic differences in response to zinc supplementation at play in diabetes management.

7 Nov 2014

Salk Institute researchers heal injured hearts of living mice

Researchers at the Salk Institute have healed injured hearts of living mice by reactivating long dormant molecular machinery found in the animals' cells, a finding that could help pave the way to new therapies for heart disorders in humans.

7 Nov 2014

Obeticholic acid improves liver health in people with nonalcoholic steatohepatitis

An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the National Institutes of Health. The FLINT study found that people with nonalcoholic steatohepatitis (NASH) who took obeticholic acid (OCA) had improved liver health during that period, including decreased inflammation and fat in the liver and decreased body weight versus people receiving a placebo. OCA was also associated with increases in itching and total cholesterol.

7 Nov 2014

Diabetes News and Research

Latest Diabetes News and Research

Concordia Healthcare reports record revenues of 147% in third quarter 2014

AADE offers self-care tips for people with diabetes

Eye screenings of underserved populations reveal one in five has early stage diabetic retinopathy

Scientists receive NARSAD Distinguished Investigator Grants for mental health research

Metabolic syndrome screening in bipolar disorder warranted

Study: Fast-food outlets in inner city neighborhoods linked to risk of diabetes, obesity

Studies evaluate traditional management of heart attack patients after discharge from hospital

Study examines overall survival of patients with chronic HCV infection, cirrhosis

Successful treatments help HIV-infected persons achieve similar longevity as those without HIV

Five simple steps to reduce type-2 diabetes

Stockholm researchers discover new mechanism that stimulates glucose uptake in brown fat

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Study points to major role of obesity in triggering, prolonging autoimmune diseases

New model explains how immune cells recognize, destroy bacteria

Surgical treatment of obesity, diabetes as safe as other commonly performed surgical procedures

Regenerative medicine may offer new standard of advanced treatment for foot and leg ulcers

Health benefits of modified formulation of curcumin supplements

Zinc supplements more beneficial for some people with diabetes

Salk Institute researchers heal injured hearts of living mice

Obeticholic acid improves liver health in people with nonalcoholic steatohepatitis

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Diabetes News and Research

Latest Diabetes News and Research

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Newsletters you may be interested in